Center for Scientific Review; Notice of Closed Meetings, 83696-83697 [2024-23872]

Download as PDF 83696 Federal Register / Vol. 89, No. 201 / Thursday, October 17, 2024 / Notices Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867–5309, gnatenkod2@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Digestive Sciences. Date: November 14–15, 2024. Time: 8:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Address: North Bethesda Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Meeting Format: In Person. Contact Person: Ganesan Ramesh, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD 20892, 301–827– 5467, ganesan.ramesh@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Cardiovascular and Surgical Devices. Date: November 14–15, 2024. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Willard Wilson, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20817, 301–867–5309, willard.wilson@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; RFA: Research for Low Vision and Blindness Accessibility Tools (R61/R33). Date: November 20, 2024. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Address: National Eye Institute, 6700 Rockledge Dr., Bethesda, MD 20817. Meeting Format: Virtual Meeting. Contact Person: Brian Hoshaw, Ph.D., Chief, Scientific Review Branch, Division of Extramural Research, National Eye Institute, National Institutes of Health, 6700 B Rockledge Dr., Rockville, MD 20892, 301– 451–2020, hoshawb@mail.nih.gov. Name of Committee: National Eye Institute Special Emphasis Panel; Conference Grant Applications (R13). Date: November 21, 2024. Time: 10:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Address: National Eye Institute, 6700 Rockledge Dr., Bethesda, MD 20817. Meeting Format: Virtual Meeting. Contact Person: Jennifer C Schiltz, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, National Eye Institute, Bethesda, MD 20817, 240–276–5864, jennifer.schiltz@nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.867, Vision Research, National Institutes of Health, HHS) Dated: October 10, 2024 Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. Dated: October 10, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–23873 Filed 10–16–24; 8:45 am] [FR Doc. 2024–23934 Filed 10–16–24; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–P BILLING CODE 4140–01–P National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES Center for Scientific Review; Notice of Closed Meetings National Institutes of Health ddrumheller on DSK120RN23PROD with NOTICES1 National Eye Institute; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning VerDate Sep<11>2014 18:31 Oct 16, 2024 Jkt 265001 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Oncology. Date: November 12–13, 2024. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Nywana Sizemore, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6189, MSC 7804, Bethesda, MD 20892, 301–408– 9916, email: sizemoren@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Infrastructure Development Training Program for Critical HIV Research at LMIC Institutions (G11). Date: November 12, 2024. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Shinako Takada, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301–827–5997, shinako.takada@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Viral Dynamics, Hypersensitivity and Allergy. Date: November 12, 2024. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Shannon J. Sherman, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301–594–0715, shannon.sherman@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Nucleic Acid Therapeutic Delivery (NATD). Date: November 13–14, 2024. Time: 8:00 a.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Address: The Bethesdan Hotel, 8120 Wisconsin Avenue, Bethesda, MD 20814. Meeting Format: In Person. Contact Person: Jingwu Xie, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–8625, jingwu.xie@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA Panel: Understanding Chronic Conditions Understudied Among Women. Date: November 13–14, 2024. Time: 9:30 a.m. to 6:30 p.m. E:\FR\FM\17OCN1.SGM 17OCN1 ddrumheller on DSK120RN23PROD with NOTICES1 Federal Register / Vol. 89, No. 201 / Thursday, October 17, 2024 / Notices Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Jessica Bellinger, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3158, Bethesda, MD 20892, (301) 827–4446, bellingerjd@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: SBIR/STTR Commercialization Readiness Pilot (CRP) Program. Date: November 13–14, 2024. Time: 9:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: In Person and Virtual Meeting. Contact Person: Marie-Jose Belanger, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Rm. 6188, MSC 7804, Bethesda, MD 20892, 301–435– 1267, belangerm@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Bioengineering, Surgery, Anesthesiology, and Trauma. Date: November 13, 2024. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Donald Scott Wright, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5108, MSC 7854, Bethesda, MD 20892, (301) 435– 8363, wrightds@csr.nih.gov. Name of Committee: Infectious Diseases and Immunology A Integrated Review Group; HIV Molecular Virology, Cell Biology, and Drug Development Study Section. Date: November 13–14, 2024. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Kenneth A. Roebuck, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5214, MSC 7852, Bethesda, MD 20892, (301) 435– 1166, roebuckk@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Metabolism and Reproductive Sciences. Date: November 13, 2024. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. VerDate Sep<11>2014 18:31 Oct 16, 2024 Jkt 265001 Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Hui Chen, MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6164, Bethesda, MD 20892, 301– 435–1044, chenhui@csr.nih.gov. Name of Committee: Infectious Diseases and Immunology B Integrated Review Group; HIV Immunopathogenesis and Vaccine Development Study Section. Date: November 14–15, 2024. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Address: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW, Washington, DC 20015. Meeting Format: In Person. Contact Person: Philip Owens, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Dr., Bethesda, MD 20892, (301) 594–7394, owensp2@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 10, 2024. Bruce A. George, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–23872 Filed 10–16–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF THE INTERIOR Fish and Wildlife Service [FWS–HQ–FAC–2024–N054; FXFR13360900000–245–FF09F14000] Aquatic Nuisance Species Task Force Meeting Fish and Wildlife Service, Interior. ACTION: Notice of meeting. AGENCY: The U.S. Fish and Wildlife Service gives notice of a public meeting of the Aquatic Nuisance Species (ANS) Task Force, in accordance with the Federal Advisory Committee Act. The ANS Task Force’s purpose is to develop and implement a program for U.S. waters to prevent introduction and dispersal of aquatic invasive species; to monitor, control, and study such species; and to disseminate related information. DATES: The ANS Task Force will meet Wednesday and Thursday, November 6– 7, 2024, from 10 a.m. to 5 p.m. each day (eastern time). Registration: Registration is required. The deadline for registration is SUMMARY: PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 83697 November 4, 2024. Also see ‘‘Public Input,’’ below. Accessibility: The deadline for accessibility accommodation requests is November 1, 2024. Please see ‘‘Requests for Accommodations,’’ below. ADDRESSES: The meeting will be held via teleconference and broadcast over the internet. To register and receive the web address and telephone number for participation, contact the Executive Secretary (see FOR FURTHER INFORMATION CONTACT) or visit the ANS Task Force website at https://www.fws.gov/ program/aquatic-nuisance-species-taskforce. FOR FURTHER INFORMATION CONTACT: Susan Pasko, Executive Secretary, ANS Task Force, by telephone at 571–623– 0608, or by email at Susan_Pasko@ fws.gov. Individuals in the United States who are deaf, deafblind, hard of hearing, or have a speech disability may dial 711 (TTY, TDD, or TeleBraille) to access telecommunications relay services. Individuals outside the United States should use the relay services offered within their country to make international calls to the point-ofcontact in the United States. SUPPLEMENTARY INFORMATION: Introduction The Aquatic Nuisance Species (ANS) Task Force was established by the Nonindigenous Aquatic Nuisance Prevention and Control Act of 1990, as amended (16 U.S.C. 4721–4728), and is composed of Federal and ex-officio members. The ANS Task Force’s purpose is to develop and implement a program for U.S. waters to prevent introduction and dispersal of aquatic invasive species; to monitor, control, and study such species; and to disseminate related information. Meeting Information This meeting is open to the public. The meeting agenda will include reports from ANS Task Force members and subcommittees; discussion on priority outputs to advance the goals identified in the ANS Task Force Strategic Plan for 2020–2025; a presentation by the U.S Geological Survey on new species occurrences in the United States; recommendations by the ANS Task Force regional panels; and public comment. The final agenda and other related meeting information will be posted on the ANS Task Force website, https://www.fws.gov/program/aquaticnuisance-species-task-force. Public Input If you wish to provide oral public comment or provide a written comment E:\FR\FM\17OCN1.SGM 17OCN1

Agencies

[Federal Register Volume 89, Number 201 (Thursday, October 17, 2024)]
[Notices]
[Pages 83696-83697]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23872]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Oncology.
    Date: November 12-13, 2024.
    Time: 10:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Nywana Sizemore, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6189, MSC 7804, Bethesda, MD 
20892, 301-408-9916, email: [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Infrastructure Development Training Program for Critical HIV 
Research at LMIC Institutions (G11).
    Date: November 12, 2024.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Shinako Takada, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-827-5997, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Topics in Viral Dynamics, Hypersensitivity 
and Allergy.
    Date: November 12, 2024.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Shannon J. Sherman, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-594-0715, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Nucleic Acid Therapeutic Delivery (NATD).
    Date: November 13-14, 2024.
    Time: 8:00 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: The Bethesdan Hotel, 8120 Wisconsin Avenue, Bethesda, 
MD 20814.
    Meeting Format: In Person.
    Contact Person: Jingwu Xie, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (301) 594-8625, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; RFA Panel: Understanding Chronic Conditions Understudied 
Among Women.
    Date: November 13-14, 2024.
    Time: 9:30 a.m. to 6:30 p.m.

[[Page 83697]]

    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Jessica Bellinger, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3158, Bethesda, MD 20892, (301) 
827-4446, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: SBIR/STTR Commercialization Readiness Pilot 
(CRP) Program.
    Date: November 13-14, 2024.
    Time: 9:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: In Person and Virtual Meeting.
    Contact Person: Marie-Jose Belanger, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Rm. 6188, MSC 7804, Bethesda, MD 
20892, 301-435-1267, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Bioengineering, Surgery, Anesthesiology, and 
Trauma.
    Date: November 13, 2024.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Donald Scott Wright, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5108, MSC 7854, Bethesda, MD 
20892, (301) 435-8363, [email protected].

    Name of Committee: Infectious Diseases and Immunology A 
Integrated Review Group; HIV Molecular Virology, Cell Biology, and 
Drug Development Study Section.
    Date: November 13-14, 2024.
    Time: 10:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Kenneth A. Roebuck, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5214, MSC 7852, Bethesda, MD 
20892, (301) 435-1166, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Topics in Metabolism and Reproductive 
Sciences.
    Date: November 13, 2024.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Hui Chen, MD, Scientific Review Officer, Center 
for Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 6164, Bethesda, MD 20892, 301-435-1044, 
[email protected].

    Name of Committee: Infectious Diseases and Immunology B 
Integrated Review Group; HIV Immunopathogenesis and Vaccine 
Development Study Section.
    Date: November 14-15, 2024.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: Embassy Suites at the Chevy Chase Pavilion, 4300 
Military Road NW, Washington, DC 20015.
    Meeting Format: In Person.
    Contact Person: Philip Owens, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Dr., Bethesda, MD 20892, (301) 594-7394, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: October 10, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-23872 Filed 10-16-24; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.